Phalanx Group to Make Debut at J.P. Morgan Healthcare Conference with Keynote Address by CFO & CIO Julian Zhu

From January 9 to 12, 2023 (Pacific Time), the highly anticipated 41st J.P. Morgan Healthcare Conference will be held in San Francisco, California. Fapon Biotech, a leading domestic life sciences enterprise, will attend the conference for the first time as an invited participant. Mr. Zhu Jielen, Chief Financial Officer (CFO) and Chief Investment Officer (CIO) of Fapon Biotech, will represent the company at the event and deliver a keynote speech on the morning of January 11, sharing Fapon Biotech’s in-depth insights into the frontiers of life sciences and its strategic business layout.

The J.P. Morgan Healthcare Conference is currently the largest and most information-rich healthcare investment symposium in the global industry, having become a bellwether for the worldwide healthcare sector. As in previous years, this year’s conference continues to bring together global industry leaders, fast-growing emerging companies, innovators of cutting-edge technologies, and members of the investment community to jointly discuss the latest trends and future directions of the healthcare industry.

Fupeng Group strategically focuses on three core business areas: foundational diagnostic technology platforms, innovative biotechnology platforms, and data computational science. Adhering to innovation as its core driver, the Group has established a global R&D, manufacturing, marketing, and service network. Its products are exported to 61 countries and regions worldwide, serving up to 1,500 global customer partners. With a focus on future human health management needs and medical development trends, Fupeng Group concentrates on the frontiers of life sciences, committed to driving industrial advancement through innovation and building a healthier, more progressive world for the future.

Mr. Zhu Jielun brings over 16 years of experience spanning investment banking and strategic consulting, establishing himself as a leading capital markets expert in the life sciences and healthcare sectors. Currently serving as Chief Financial Officer (CFO) and Chief Investment Officer (CIO) of Fapon Group, he is fully responsible for formulating and implementing comprehensive capital strategies across all business units, as well as overseeing mergers and acquisitions, strategic investments, post-investment management, and the incubation of early-stage high-growth ventures.